Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Ulcerative Colitis (UC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT03758443
What this trial is testing

Efficacy & Safety of TD-1473 in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Theravance Biopharma 239
Large-scale testing (Phase 3)Study completedNCT01008423
What this trial is testing

Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis

Who this might be right for
ProctitisProctosigmoiditis
Bausch Health Americas, Inc. 281
Early research (Phase 1)Ended earlyNCT03943550
What this trial is testing

Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 45
Early research (Phase 1)Not Yet RecruitingNCT07744646
What this trial is testing

Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
The First Affiliated Hospital of Anhui Medical University 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06725017
What this trial is testing

Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Guangzhou Zhiyi Biotechnology Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT04205643
What this trial is testing

CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)

Who this might be right for
Ulcerative Colitis
Celltrion 548
Not applicableNot Yet RecruitingNCT07358923
What this trial is testing

Accuracy of Modified Milan Ultrasound Criteria in Assessing Disease Activity and Severity in Moderate-to-Severe Ulcerative Colitis: a Pilot Study

Who this might be right for
Ulcerative Colitis (UC)
IRCCS San Raffaele 25
Early research (Phase 1)Study completedNCT05084261
What this trial is testing

An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Adiso Therapeutics 24
Testing effectiveness (Phase 2)Ended earlyNCT01659138
What this trial is testing

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sanofi 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07747155
What this trial is testing

Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Pyrotech Therapeutics, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT07692165
What this trial is testing

A Phase Ib/IIa Study of INT-210 Capsules in Participants With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Innatus Therapeutics (Shanghai) Co., Ltd. 24
Early research (Phase 1)Study completedNCT04924114
What this trial is testing

MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)

Who this might be right for
Ulcerative Colitis
Merck Sharp & Dohme LLC 57
Large-scale testing (Phase 3)Study completedNCT04706793
What this trial is testing

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

Who this might be right for
Ulcerative Colitis
Pfizer 42
Early research (Phase 1)Ended earlyNCT06681389
What this trial is testing

NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis

Who this might be right for
Healthy Adult VolunteersActive Ulcerative ColitisActive Ulcerative Colitis (UC)
NIBEC Co., Ltd. 35
Early research (Phase 1)Study completedNCT00295282
What this trial is testing

A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 24
Testing effectiveness (Phase 2)Looking for participantsNCT07507513
What this trial is testing

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

Who this might be right for
Ulcerative Colitis (UC)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 288
Large-scale testing (Phase 3)Study completedNCT00410410
What this trial is testing

Abatacept in Patients With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 591
Testing effectiveness (Phase 2)Active Not RecruitingNCT05731128
What this trial is testing

Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))

Who this might be right for
Colitis Ulcerative
Sanofi 68
Not applicableLooking for participantsNCT06756100
What this trial is testing

Early Inflammatory Bowel Disease Progression

Who this might be right for
Inflammatory Bowel DiseasesCrohn Disease (CD)Ulcerative Colitis (UC)
Pontificia Universidad Catolica de Chile 140
Not applicableStudy completedNCT00781638
What this trial is testing

ADAPT Adacolumn Pediatric Trial in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Otsuka Frankfurt Research Institute GmbH 24
Next Page